WOMEN'S ISCHEMIC SYMPTOM EVALUATION (WISE)

女性缺血症状评估（WISE）

• 批准号: 6219970
• 负责人: Cathleen Noel Bairey Merz
• 金额: $ 0.1万
• 依托单位: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6219970
• 关键词: clinical research; female; heart disorder; hormones; human subject; ischemia; pathologic process; sign /symptom; vasoconstriction; women's health

The WISE is a multi-center study designed to help understand heart disease in women via studies of vasoconstriction, cardiac blood flow, questionnaire cardiac symptomatology, and measurement of circulatory hormone levels. Women are being recruited for this study at the universities in Pittsburgh, Florida, Alabama, and Allegheny General Hospital. CSMC is functioning as the core laboratory for the blood hormone determinations. Blood samples are shipped from the four study sites to the GCRC at Cedars-Sinai, where they are collated and triaged.

WISE是一项多中心研究，旨在通过研究血管收缩、心脏血流量、问卷心脏病学和测量循环激素水平来帮助了解女性心脏病。匹兹堡、佛罗里达、亚拉巴马和阿勒格尼总医院的大学正在招募妇女参加这项研究。 CSMC是血液激素测定的核心实验室。 血液样本从四个研究中心运送到Cedars-Sinai的GCRC，在那里进行整理和分类。